Universidade Federal do Rio Grande do Norte Natal, 06 de Junho de 2024

Resumo do Componente Curricular

Dados Gerais do Componente Curricular
Tipo do Componente Curricular: MÓDULO
Unidade Responsável: PROGRAMA DE PÓS-GRADUAÇÃO EM NEUROCIÊNCIAS (10.89.00.05)
Código: NEU0084
Nome: CIÊNCIA E MEDICINA PSICODÉLICA
Carga Horária Teórica: 60 h.
Carga Horária Prática: 0 h.
Carga Horária de Ead: 0 h.
Carga Horária Total: 60 h.
Pré-Requisitos:
Co-Requisitos:
Equivalências:
Excluir da Avaliação Institucional: Não
Matriculável On-Line: Sim
Horário Flexível da Turma: Não
Horário Flexível do Docente: Sim
Obrigatoriedade de Nota Final: Sim
Pode Criar Turma Sem Solicitação: Não
Necessita de Orientador: Não
Exige Horário: Sim
Permite CH Compartilhada: Não
Quantidade de Avaliações: 1
Ementa/Descrição: Histórico da pesquisa e experimentação com substâncias psicodélicas. Neurobiologia, comportamento e uso clínico das substâncias psicodélicas. Modelos clínicos de uso de substâncias psicodélicas. Fonteiras das pesquisas com substâncias psicodélicas.
Referências: Bogenschutz, M. P., & Forcehimes, A. A. (2017). Development of a psychotherapeutic model for psilocybin-assisted treatment of alcoholism. Journal of Humanistic Psychology, 57(4), 389-414. Carhart-Harris, R. L., & Friston, K. J. (2019). REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacological reviews, 71(3), 316-344. de Araujo DB, Ribeiro S, Cecchi GA, Carvalho FM, Sanchez TA, Pinto JP, de Martinis BS, Crippa JA, Hallak JE, Santos AC. Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion. Human brain mapping. 2012 Nov;33(11):2550-60. Fotiou, E. (2019). The role of Indigenous knowledges in psychedelic science. Journal of Psychedelic Studies 4(18), 1 - 8. Garcia-Romeu, A., Kersgaard, B., Addy, P. (2016). Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology 24(4), 229 - 268. Johnson, M., Richards, W., Griffiths, R. (2008). Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology 22(6), 603 - 620. Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmerman, C., Rodriguez, N., ... & Carhart-Harris, R. (2018). The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology, 235(2), 505-519. Kirmayer, L. J. (2004). The cultural diversity of healing: meaning, metaphor and mechanism. British medical bulletin, 69(1), 33-48. Nichols, D. (2016). Psychedelics. Pharmacological Reviews 68(2), 264 - 355. Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, Ribeiro S, de Araujo DB. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PloS one. 2015 Feb 18;10(2):e0118143. Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, ..., de Araujo DB. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychological medicine. 2019 Mar;49(4):655-63. Phelps, J. (2017). Developing guidelines and competencies for the training of psychedelic therapists. Journal of Humanistic Psychology 57(5), 450 - 487. Rucker, J. J., Iliff, J., & Nutt, D. J. (2018). Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology, 142, 200-218. Swift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., ...& Ross, S. (2017). Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. Journal of Humanistic Psychology, 57(5), 488-519. Video (Start at 5:45min): Pollan, Michael. Psychedelics and How to Change Your Mind. Bioneers. 2018. https://www.youtube.com/watch?v=5DrM90dg5t4 Video (Watch from 0:00 – 8:00 min): LSD’s Long Strange Trip. Retro Report, The New York Times. 2016. https://www.youtube.com/watch?v=WouOr579mfY&has_verified=1 Bogenschutz, M. P., & Forcehimes, A. A. (2017). Development of a psychotherapeutic model for psilocybin-assisted treatment of alcoholism. Journal of Humanistic Psychology, 57(4), 389-414. Carhart-Harris, R. L., & Friston, K. J. (2019). REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacological reviews, 71(3), 316-344. de Araujo DB, Ribeiro S, Cecchi GA, Carvalho FM, Sanchez TA, Pinto JP, de Martinis BS, Crippa JA, Hallak JE, Santos AC. Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion. Human brain mapping. 2012 Nov;33(11):2550-60. Fotiou, E. (2019). The role of Indigenous knowledges in psychedelic science. Journal of Psychedelic Studies 4(18), 1 - 8. Garcia-Romeu, A., Kersgaard, B., Addy, P. (2016). Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology 24(4), 229 - 268. Johnson, M., Richards, W., Griffiths, R. (2008). Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology 22(6), 603 - 620. Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmerman, C., Rodriguez, N., ... & Carhart-Harris, R. (2018). The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology, 235(2), 505-519. Kirmayer, L. J. (2004). The cultural diversity of healing: meaning, metaphor and mechanism. British medical bulletin, 69(1), 33-48. Nichols, D. (2016). Psychedelics. Pharmacological Reviews 68(2), 264 - 355. Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, Ribeiro S, de Araujo DB. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PloS one. 2015 Feb 18;10(2):e0118143. Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, ..., de Araujo DB. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychological medicine. 2019 Mar;49(4):655-63. Phelps, J. (2017). Developing guidelines and competencies for the training of psychedelic therapists. Journal of Humanistic Psychology 57(5), 450 - 487. Rucker, J. J., Iliff, J., & Nutt, D. J. (2018). Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology, 142, 200-218. Swift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., ...& Ross, S. (2017). Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. Journal of Humanistic Psychology, 57(5), 488-519. Video (Start at 5:45min): Pollan, Michael. Psychedelics and How to Change Your Mind. Bioneers. 2018. https://www.youtube.com/watch?v=5DrM90dg5t4 Video (Watch from 0:00 – 8:00 min): LSD’s Long Strange Trip. Retro Report, The New York Times. 2016. https://www.youtube.com/watch?v=WouOr579mfY&has_verified=1

SIGAA | Superintendência de Tecnologia da Informação - (84) 3342 2210 | Copyright © 2006-2024 - UFRN - sigaa12-producao.info.ufrn.br.sigaa12-producao v4.12.24